192 related articles for article (PubMed ID: 35743204)
1. Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions.
Manzi L; Sepe N; Migliaccio W; Lanzoni L; Iozzino L; D'Angelo F; Colarusso L; Montenegro S; Palmese A; D'Hooghe T; Ulloa-Aguirre A; Koloda Y; Lispi M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743204
[TBL] [Abstract][Full Text] [Related]
2. Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.
Chua SJ; Mol BW; Longobardi S; Orvieto R; Venetis CA; Lispi M; Storr A; D'Hooghe T
Reprod Biol Endocrinol; 2021 Apr; 19(1):51. PubMed ID: 33794909
[TBL] [Abstract][Full Text] [Related]
3. In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f).
Mastrangeli R; Satwekar A; Cutillo F; Ciampolillo C; Palinsky W; Longobardi S
PLoS One; 2017; 12(9):e0184139. PubMed ID: 28880909
[TBL] [Abstract][Full Text] [Related]
4. Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology related to fresh embryo transfers.
Schwarze JE; Venetis C; Iniesta S; Falla E; Lukyanov V; de Agustin Calvo E; D Hooghe T; Roeder C; Matorras R
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):203-216. PubMed ID: 35227619
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
[TBL] [Abstract][Full Text] [Related]
6. Overlapping biosimilar and originator follitropin alfa preparations: How much closer can they get?
de Mora F; Howles CM
Drug Discov Today; 2022 Aug; 27(8):2071-2075. PubMed ID: 35490965
[TBL] [Abstract][Full Text] [Related]
7. Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment.
Agostinetto R
Reprod Biol Endocrinol; 2009 May; 7():48. PubMed ID: 19450267
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany.
Bühler KF; Fischer R; Verpillat P; Allignol A; Guedes S; Boutmy E; Bilger W; Richter E; D'Hooghe T
Reprod Biol Endocrinol; 2021 Jun; 19(1):90. PubMed ID: 34134695
[TBL] [Abstract][Full Text] [Related]
9. A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy and Spain.
Gizzo S; Ferrando M; Lispi M; Ripellino C; Cataldo N; Bühler K
J Med Econ; 2018 Nov; 21(11):1096-1101. PubMed ID: 30113238
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies.
Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM
BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of gonadotropins used for ovarian stimulation during assisted reproductive technologies (ART) in France: A real-world observational study from the French nationwide claims database (SNDS).
Grynberg M; Cedrin-Durnerin I; Raguideau F; Herquelot E; Luciani L; Porte F; Verpillat P; Helwig C; Schwarze JE; Paillet S; Castello-Bridoux C; D'Hooghe T; Benchaïb M
Best Pract Res Clin Obstet Gynaecol; 2023 Jun; 88():102308. PubMed ID: 36707343
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation Pattern and
Riccetti L; Sperduti S; Lazzaretti C; Klett D; De Pascali F; Paradiso E; Limoncella S; Potì F; Tagliavini S; Trenti T; Galano E; Palmese A; Satwekar A; Daolio J; Nicoli A; Villani MT; Aguzzoli L; Reiter E; Simoni M; Casarini L
Front Endocrinol (Lausanne); 2019; 10():503. PubMed ID: 31396162
[TBL] [Abstract][Full Text] [Related]
13. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
Picard M; Rossier C; Papasouliotis O; Lugan I
Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
[TBL] [Abstract][Full Text] [Related]
14. XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders.
Hoy SM
BioDrugs; 2016 Aug; 30(4):379-86. PubMed ID: 27342604
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha.
Barakhoeva Z; Vovk L; Fetisova Y; Marilova N; Ovchinnikova M; Tischenko M; Scherbatyuk Y; Kolotovkina A; Miskun A; Kasyanova G; Teterina T; Zorina I; Belousova N; Morozova E; Yakovenko S; Apryshko V; Sichinava L; Shalinа R; Polzikov M
Eur J Obstet Gynecol Reprod Biol; 2019 Oct; 241():6-12. PubMed ID: 31400644
[TBL] [Abstract][Full Text] [Related]
16. Purification Process of a Recombinant Human Follicle Stimulating Hormone Biosimilar (Primapur
Sinegubova M; Vorobiev I; Klishin A; Eremin D; Orlova N; Orlova N; Polzikov M
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35056992
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of follitropin alpha biosimilars compared to their reference product: a Meta-analysis.
Budani MC; Fensore S; Di Marzio M; Tiboni GM
Gynecol Endocrinol; 2021 May; 37(5):406-414. PubMed ID: 32654532
[TBL] [Abstract][Full Text] [Related]
18. Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development.
Abramova N; Hubbard J; Schertz J; Richter E
Drug Saf; 2019 Mar; 42(3):453-461. PubMed ID: 30341677
[TBL] [Abstract][Full Text] [Related]
19. Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK.
Lass A; McVeigh E;
Reprod Biomed Online; 2004 Dec; 9(6):604-10. PubMed ID: 15670403
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats.
Alper M; Meyer R; Dekkers C; Ezcurra D; Schertz J; Kelly E
Reprod Biol Endocrinol; 2008 Jul; 6():31. PubMed ID: 18647398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
